In this article, we investigate the range of treatments prescribed for schizoaffective disorder. The data show that the majority of those treated, 87 percent, receive two or more pharmaceutical classes. From a therapeutic class perspective, 93 percent of schizoaffective disorder patients receive an antipsychotic, 48 percent receive a mood disorder treatment, and 42 percent receive an antidepressant. An expert commentary is also included.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Aug 14 2009|
- Schizoaffective disorder
ASJC Scopus subject areas
- Psychiatry and Mental health